NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/02/2026
Voltar para busca
Dado oficial do USPTO
SERONORM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
27/02/2026
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
05/09/2017
Data de registro
25/09/2018
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/02/2025
Última transação
27/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Billingstad, NO
Examinador
ESTRADA, LINDA M
Localização atual
Historical data usage
Titulares e representantes
Titulares
S. A. (pessoa física)
S. A. (pessoa física)
Representantes
Kiranjit K Dharsan Seiter IP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biological preparationsreagents and chemical substances for scientific and research use and laboratory analysisfor control of in vitro diagnostic (IVD) analysis resultsother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for scientific and research use and laboratory analysisfor control of calibration of in vitro diagnostic (IVD) analysis instrumentsother than for medicalpharmaceutical or veterinary use; the before-mentioned goods excluding botanical extracts for use in the preparation of pharmaceutical productscosmetics and foodstuffexcluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation inductionimmunologypediatrics and endocrinologyauto immune diseasesgrowth and metabolismdiseases of the central nervous systemcancerviral diseasesinflammatory disorders
Classe 5
Medical diagnostic preparations used to control the results of medical analysisblood teststhat laboratories perform in order to diagnose and treat patients; the before-mentioned goods excluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation inductionimmunologypediatrics and endocrinologyauto immune diseasesgrowth and metabolismdiseases of the central nervous systemcancerviral diseasesinflammatory disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/02/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/02/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/02/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
24/02/2025
71AG
REGISTERED-SEC.71 ACCEPTED
24/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/02/2025
ES71
TEAS SECTION 71 RECEIVED
18/09/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/01/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/11/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/09/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/02/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/01/2019
FIMP
FINAL DISPOSITION PROCESSED
13/01/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
25/09/2018
GPNX
NOTIFICATION PROCESSED BY IB
20/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/07/2018
PUBO
PUBLISHED FOR OPPOSITION
10/07/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/05/2018
RFNT
REFUSAL PROCESSED BY IB
19/01/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/12/2017
RFRR
REFUSAL PROCESSED BY MPU
28/12/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/12/2017
CNRT
NON-FINAL ACTION WRITTEN
13/12/2017
MAFR
APPLICATION FILING RECEIPT MAILED
12/12/2017
DOCK
ASSIGNED TO EXAMINER
08/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SERONORM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.